FindTrial
Sign In

USE OF BENZODIAZEPINE IN THE TREATMENT OF ALCOHOL WITHDRAWAL SYMPTOMS IN A TEACHING HOSPITAL.

CLINICAL UTILITY OF BENZODIAZEPINE IN THE MANAGEMENT OF ALCOHOL WITHDRAWAL SYNDROME IN A TERTIARY CARE TEACHING HOSPITAL.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/04/018624
Enrollment
220
Registered
2019-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F102- Alcohol dependence

Interventions

None listed

Sponsors

Nitte Deemed to be University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: inclusion: In patients in psychiatry de-addiction ward. Patients who are willing to participate in the study. Age group 18 and above.

Exclusion criteria

Exclusion criteria: exclusion: Patients diagnosed with psychosis. Severe medical illness or injuries. Other substance abuse(except nicotine)

Design outcomes

Primary

MeasureTime frame
The study assesses the efficacy of different Benzodiazepines in reducing alcohol withdrawal syndrome. Optimizing the therapeutic outcomes and preventing further complications.Timepoint: Single point—

Secondary

MeasureTime frame
Useful in identifying rationality of drugs. Timepoint: Single point—

Countries

India

Contacts

Public ContactBharathraj ks

NGSM Institue of Pharmaceutical Sciences.

rajeshks@nitte.edu.in08050347455

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026